Loading...

Pre-clinical immunotoxicity studies of nanotechnology-formulated drugs: challenges, considerations and strategy

Assorted challenges in physicochemical characterization, sterilization, depyrogenation, and in the assessment of pharmacology, safety, and efficacy profiles accompany preclinical development of nanotechnology-formulated drugs. Some of these challenges are not unique to nanotechnology and are common...

Full description

Saved in:
Bibliographic Details
Published in:J Control Release
Main Author: Dobrovolskaia, Marina A.
Format: Artigo
Language:Inglês
Published: 2015
Subjects:
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC4688153/
https://ncbi.nlm.nih.gov/pubmed/26348388
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jconrel.2015.08.056
Tags: Add Tag
No Tags, Be the first to tag this record!